DNA clues could help predict liver failure in hepatitis b patients
NCT ID NCT07275554
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at DNA methylation patterns in 100 people with severe liver failure caused by hepatitis B. Researchers aim to build a model that predicts how the disease will progress, which could help doctors make better treatment decisions. The study is observational and does not test a new drug or treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a better way to predict outcomes and guide treatment for patients with severe hepatitis B-related liver failure.
- What could go wrong
- This is an early observational study with only 100 participants, so the findings may not apply to all patients. The model needs further validation before it can be used in practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HBV (HEPATITIS B VIRUS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Qilu Hospital of Shandong University
RECRUITINGJinan, Shandong, 250012, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can the liver heal itself? new study tracks unexpected recovery in cirrhosis patients
- New All-in-One test could save thousands of babies from infections
- Simple computer alert could help doctors catch hidden HIV and hepatitis cases
- Chinatown screening drive aims to uncover silent hepatitis infections
- 5000 hepatitis b patients to be tracked for immune clues
- AI could spot liver cancer early in hepatitis b patients